Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Integrin α L Inhibitors

Santa Cruz Biotechnology now offers a broad range of Integrin αL Inhibitors for use in various applications. Integrin αL, also known as CD11a, is a subunit of the LFA-1 (lymphocyte function-associated antigen-1) integrin complex, which plays a crucial role in the immune system by mediating cell adhesion and signal transduction during immune responses. Integrin αL is particularly important in the interaction between T-cells and antigen-presenting cells, as well as in the migration of leukocytes to sites of inflammation. Integrin αL Inhibitors are essential tools in scientific research, enabling researchers to study the mechanisms of immune cell adhesion, migration, and activation. By inhibiting Integrin αL, scientists can explore how the disruption of these processes affects immune function, providing insights into the regulation of immune responses and the development of inflammatory conditions. These inhibitors are widely used in studies focused on understanding the molecular pathways involved in immune cell communication and the role of integrins in the pathogenesis of autoimmune diseases, chronic inflammation, and transplant rejection. Additionally, Integrin αL Inhibitors are valuable in research aimed at developing new strategies for modulating the immune system in various diseases. The availability of these inhibitors has significantly advanced research in immunology, cell biology, and molecular biology, offering critical tools for investigating the complex interactions that govern immune responses. View detailed information on our available Integrin αL Inhibitors by clicking on the product name.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

A 286982

280749-17-9sc-362705
sc-362705A
10 mg
50 mg
$213.00
$898.00
2
(0)

A 286982 serves as a potent integrin alpha L inhibitor, exhibiting a unique mechanism of action through its selective binding to the integrin's ligand-binding domain. This interaction disrupts the conformational stability of integrin complexes, leading to altered cellular signaling pathways. The compound demonstrates a distinctive kinetic behavior, characterized by a slow dissociation rate, which enhances its efficacy in modulating integrin-mediated cellular responses. Its specificity underscores its potential in influencing immune cell adhesion and migration.